Skip to main content
SpringerLink
Log in

Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients

  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

There is growing controversy over the cost-effectiveness of surveillance endoscopy for patients with Barrett’s esophagus. A retrospective review was performed of 80 patients who underwent resection for Barrett’s adenocarcinoma to assess the influence of endoscopic surveillance on long-term survival. Twelve patients initially were diagnosed with benign Barrett’s esophagus and were followed with endoscopic surveillance. The remaining 68 patients had the diagnosis of Barrett’s esophagus made at the time of their cancer diagnosis or resection. Patients in surveillance programs were younger (53 vs. 64 years; P = 0.008), had better performance status (8.9 vs. 8.2; P = 0.04), had less weight loss (0.3 vs. 5.5 kg; P < 0.001), had a similar incidence of gastroesophageal reflux disease symptoms (75% vs. 60%), and were less likely to undergo preoperative chemotherapy and/or radiation therapy (8% vs. 28%). Pathologic stage was 0 or I in 9 (75%) of 12 patients in the surveillance group compared to 12 (18%) of 68 of those in the no surveillance group (P < 0.001). Median survival for patients in the surveillance group was 107 months compared to 12 months for those in the no surveillance group (P < 0.001). Stratifying for stage, surveillance (hazard ratio = 3.05; confidence interval = 1.09 to 8.57; P = 0.034) was the only predictor of survival. Surveillance endoscopy permits early diagnosis of adenocarcinoma in patients with Barrett’s esophagus and contributes substantially to long-term survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett’s esophagus. J Thorac Cardiovasc Surg 1993;105:383–388.

    PubMed  Google Scholar 

  2. Peters JH, Clark GWB, Ireland AP, Chandrasoma P, Smyrk TC, DeMeester TR. Outcome of adenocarcinoma arising in Barrett’s esophagus in endoscopically surveyed and nonsurveyed patients. J Thorac Cardiovasc Surg 1994; 108:813–822.

    PubMed  CAS  Google Scholar 

  3. van Sandick JW, van Lanschot JJB, Kuiken BW, Tytgat GNJ, Offerhaus GJA, Obertop H. Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut 1998; 43:216–222.

    Article  PubMed  Google Scholar 

  4. Macdonald CE, Wicks AC, Playford RJ. Final results from 10 year cohort of patients undergoing surveillance for Barrett’s oesophagus: Observational study. BMJ 2000;321:1252–1255.

    Article  PubMed  CAS  Google Scholar 

  5. Gross CP, Canto MI, Hixson J, Powe NR. Management of Barrett’s esophagus: A national study of practice patterns and their cost implications. Am J Gastroenterol 1999;94:3440–3447.

    Article  PubMed  CAS  Google Scholar 

  6. Provenzale D, Schmitt C, Wong JB. Barrett’s esophagus: A new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999;94:2043–2053.

    Article  PubMed  CAS  Google Scholar 

  7. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H, MacDonald W, Owen D. Observer variation in the diagnosis of dysplasia in Barrett’s esophagus. Hum Pathol 1988;19:166–178.

    Article  PubMed  CAS  Google Scholar 

  8. American Joint Committee on Cancer. AJCC Cancer Staging Manual. Philadelphia: Lippincott-Williams & Wilkins, 1997, pp. 65–69.

    Google Scholar 

  9. Chow W-H, Finkle WD, McLaughlin JK, Frankl H, Ziel HK, Fraumeni JF Jr. The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 1995;274:474–477.

    Article  PubMed  CAS  Google Scholar 

  10. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esoph-ageal adenocarcinoma. N EnglJ Med 1999;340:825–831.

    Article  CAS  Google Scholar 

  11. Farrow DC, Vaughan TL, Sweeney C, Gammon MD, Chow WH, Risch HA, Stanford JL, Hansten PD, Mayne ST, Schoenberg JB, Rotterdam H, Ahsan H, West AB, Dubrow R, Fraumeni JF Jr, Blot WJ. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000;11:231–238.

    Article  PubMed  CAS  Google Scholar 

  12. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049–2053.

    Article  PubMed  CAS  Google Scholar 

  13. Bytzer P, Christensen PB, Damkier P, Vinding K, Seer-sholm N. Adenocarcinoma of the esophagus and Barrett’s esophagus: A population-based study. Am J Gastroenterol 1999;94:86–91.

    Article  PubMed  CAS  Google Scholar 

  14. Incarbone R, Bonavina L, Szachnowicz S, Saino G, Perac-chia A. Rising incidence of esophageal adenocarcinoma in western countries: Is it possible to identify a population at risk? Dis Esoph 2000;13:275–278.

    Article  CAS  Google Scholar 

  15. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastro-esophageal reflux disease in an adult population. Ann Med 1995;27:67–70.

    PubMed  CAS  Google Scholar 

  16. Valle C, Broglia F, Pistorio A, Tinelli C, Perego M. Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease. Dig Dis Sci 1999;44:1848–1852.

    Article  PubMed  CAS  Google Scholar 

  17. Csendes A, Smok G, Burdiles P, Quesada F, Huertas C, Ro-jas J, Korn O. Prevalence of Barrett’s esophagus by endos-copy and histologic studies: A prospective evaluation of 306 control subjects and 3 76 patients with symptoms of gastroesophageal reflux. Dis Esoph 2000;13:5–11.

    Article  CAS  Google Scholar 

  18. Falk GW. Endoscopic surveillance of Barrett’s esophagus: Risk stratification and cancer risk. Gastrointest Endosc 1999; 49:829–834.

    Article  Google Scholar 

  19. Weston AP, Badr AS, Hassanein RS. Prospective multivari-ate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett’s multifocal high-grade dysplasia or adenocarcinoma. Am J Gastroenterol 1999;94:3413–3419.

    Article  PubMed  CAS  Google Scholar 

  20. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toledano AY, Shyr Y, Washington K. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmation. Hum Pathol 2001;32:368–378.

    Article  PubMed  CAS  Google Scholar 

  21. Montgomery E, Goldblum JR, Greenson JK, Haber MM, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Washington K, Zahurak ML, Hart J. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study. Hum Pathol 2001;32:379–388.

    Article  PubMed  CAS  Google Scholar 

  22. Sampliner RE, The Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett’s esophagus. Am J Gastroenterol 1998;93:1028–1032.

    Article  PubMed  CAS  Google Scholar 

  23. Soni A, Sampliner RE, Sonnenberg A. Screening for high-grade dysplasia in gastroesophageal reflux disease: Is it cost-effective? Am J Gastroenterol 2000;95:2086–2093.

    Article  PubMed  CAS  Google Scholar 

  24. Streitz JM Jr, Ellis FH Jr, Tilden RL, Erickson RV. Endoscopic surveillance of Barrett’s esophagus: A cost-effectiveness comparison with mammographic surveillance for breast cancer. AmJ Gastroenterol 1998;93:911–915.

    Article  Google Scholar 

  25. Black WC. Advances in radiology and the real versus apparent effects of early diagnosis. Eur J Radiol 1998;27:116–122.

    Article  PubMed  CAS  Google Scholar 

  26. Soda H, Oka M, Tomita H, Nagashima S, Soda M, Kohno S. Length and lead time biases in radiologic screening for lung cancer. Respiration 1999;66:511–517.

    Article  PubMed  CAS  Google Scholar 

  27. Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: Further observations on growth. Radiology 1995; 197:589–597.

    PubMed  CAS  Google Scholar 

  28. Schwartz KL, Severson RK, Gurney JG, Montie JE. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973–1994. Cancer 1996;78:1260–1266.

    Article  PubMed  CAS  Google Scholar 

  29. Potosky AL, Harlan LC, Stanford JL, Gilliland FD, Hamilton AS, Albertsen PC, Eley JW, Liff JM, Deapen D, Stephenson RA, Legler J, Ferrans CE, Talcott JA, Litwin MS. Prostate cancer practice patterns and quality of life: The Prostate Cancer Outcomes Study. J Natl Cancer Inst 1999;91:1719–1724.

    Article  PubMed  CAS  Google Scholar 

  30. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett’s oesophagus. Gut 1991;32:1441–1446.

    Article  PubMed  CAS  Google Scholar 

  31. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS. Predictors of progression to cancer in Barrett’s esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000; 95:1669–1676.

    PubMed  CAS  Google Scholar 

  32. Weston AP, Sharma P, Topalovski M, Richards R, Cherian R, Dixon A. Long-term follow up of Barrett’s high-grade dysplasia. AmJ Gastroenterol 2000;95:1888–1893.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, The University of Chicago, 5841 S. Maryland Ave., MC5035, 60637, Chicago, IL., USA

    Mark K. Ferguson M.D. & Amy Durkin M.S., P.A.-C.

Authors
  1. Mark K. Ferguson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amy Durkin M.S., P.A.-C.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark K. Ferguson M.D..

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ferguson, M.K., Durkin, A. Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients. J Gastrointest Surg 6, 29–36 (2002). https://doi.org/10.1016/S1091-255X(01)00052-X

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(01)00052-X

Key words

Search

Navigation